Ginsenoside Rg1 alleviates ANIT-induced cholestatic liver injury by inhibiting hepatic inflammation and oxidative stress via SIRT1 activation

Author:

Gao Qianyan,Li Guodong,Zu Yue,Xu Yanjiao,Wang Congyi,Xiang Dong,He Wenxi,Shang Tianze,Cheng Xinwei,Liu Dong,Zhang Chengliang

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference77 articles.

1. Comparing the efficacy and safety of obeticholic acid and semaglutide in patients with non-alcoholic fatty liver disease: a systematic review;Ahmed;Cureus,2022

2. Ginseng pharmacology: multiple constituents and multiple actions;Attele;Biochem. Pharmacol.,1999

3. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond;Beuers;J. Hepatol.,2015

4. Fine-tuning of sirtuin 1 expression is essential to protect the liver from cholestatic liver disease;Blokker;Hepatology,2019

5. SIRT1 transgenic mice show phenotypes resembling calorie restriction;Bordone;Aging Cell,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3